Wedbush Raises Price Target on Boston Scientific (BSX) to $25 Following 2Q

Notable 52-Week Highs and Lows 7/28: (FB) (BSX) (GRUB) High; (INFN) (PRLB) (MVIS) Low

July 28, 2016 3:34 PM EDT

52-Week High:Facebook (Nasdaq: FB) $128.33. Facebook reported Q2 adjusted EPS of $0.97, versus the analyst estimate of $0.82. Revenue for the quarter came in at $6.44 billion versus the consensus estimate of $6.02 billion. Mobile MAUs were 1.57 billion as of June 30, 2016, an increase of 20% year-over-year.

Boston Scientific (NYSE: BSX) $24.79. Boston Scientific reported Q2 EPS of $0.27, in-line with the analyst estimate of $0.27. Revenue for the quarter came in at... More

Boston Scientific (BSX) PT Raised to $28 at Needham & Company

July 28, 2016 2:38 PM EDT

Needham & Company analyst Mike Matson reiterated a Buy rating and bumped his price target on Boston Scientific (NYSE: BSX) to $28.00 (from $26.00) following doubled-digit organic growth in Q2.

Matson commented, "BSX beat consensus 2Q16 revenue and met consensus EPS. BSX's organic constant currency... More

Boston Scientific (BSX) PT Bumped to $26 at Evercore ISI

July 28, 2016 12:46 PM EDT

Evercore ISI analyst Vijay Kumar reiterated a Buy rating and lifted his price target on Boston Scientific (NYSE: BSX) to $26.00 (from $25.50) following results this morning.

The firm maintained FY 2016 EPS of $1.11, FY 2017 EPS of $1.30 and raised FY 2018 EPS from $1.52 to $1.55.

Kumar commented, "Just when investors sighed a breath of relief after last Q when the long awaited new product momentum drove a... More

Boston Scientific (BSX) Reports In-Line Q2 EPS; Bumps FY16 Rev View

July 28, 2016 6:34 AM EDT

Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.27, in-line with the analyst estimate of $0.27. Revenue for the quarter came in at $2.13 billion versus the consensus estimate of $2.05 billion.

"Our strong performance is evidence of the success of our category leadership strategy," said Mike... More

Trading Radar for 7/28: Alphabet (GOOG), Amazon (AMZN), Ford (F), Baidu (BIDU), MasterCard (MA) Report

July 27, 2016 2:49 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Initial Claims - Street sees 260kContinuing Claims - no Street consensusInternational Trade in Goods - ($61.2B)

Earnings:

ACI Worldwide, Inc. (Nasdaq: ACIW) - consensus loss $0.04
ARIAD Pharma (Nasdaq: ARIA) - consensus loss $0.11
Acorda Therapeutics (Nasdaq: ACOR) - consensus EPS $0.18
Agenus (Nasdaq: AGEN) - consensus... More

Boston Scientific (BSX) Acquires RFA Systems Makter Cosman Medical

July 27, 2016 9:02 AM EDT

Boston Scientific Corporation (NYSE: BSX) announced that it has acquired Cosman Medical, Inc., a privately held Burlington, Mass. manufacturer of radiofrequency ablation (RFA) systems. The Cosman Medical team and products will become part of the Boston Scientific Neuromodulation business, which offers a range of Spinal Cord Stimulator (SCS) systems to treat patients with chronic pain, and Deep Brain Stimulation systems* for the treatment of Parkinson's disease, dystonia and essential tremor.

"This acquisition is a natural extension of our current product portfolio and will help us provide physicians and patients more options to address chronic... More